Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Cellectar Biosciences, Inc. CLRB
$1.38
-$0.03 (-2.13%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
13836394.00000000
-
week52high
6.76
-
week52low
1.25
-
Revenue
0
-
P/E TTM
0
-
Beta
1.17370200
-
EPS
-3.97000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Roth Capital | Buy | 25 ноя 2020 г. | |
| Oppenheimer | Outperform | 25 ноя 2020 г. | |
| Maxim Group | Buy | 25 ноя 2020 г. | |
| Brookline Capital | Buy | 25 ноя 2020 г. | |
| Oppenheimer | Outperform | 01 июл 2020 г. | |
| HC Wainwright & Co. | Buy | Buy | 04 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Kolean Chad J | A | 104000 | 104000 | 17 янв 2023 г. |
| CARUSO JAMES V | A | 261000 | 261000 | 17 янв 2023 г. |
| Longcor Jarrod | A | 144000 | 144000 | 17 янв 2023 г. |
| Lea Darrell Shane | A | 100000 | 100000 | 21 ноя 2022 г. |
| Chanan-Khan Asher | A | 7800 | 7800 | 24 июн 2022 г. |
| DRISCOLL FREDERICK W | A | 7800 | 7800 | 24 июн 2022 г. |
| Loren Stefan | A | 7800 | 7800 | 24 июн 2022 г. |
| NEIS JOHN | A | 7800 | 7800 | 24 июн 2022 г. |
| Swirsky Douglas J | A | 11700 | 11700 | 24 июн 2022 г. |
| Kolean Chad J | A | 150000 | 150000 | 22 февр 2022 г. |
Новостная лента
Here's Why Cellectar Biosciences Shares Are Rising
Benzinga
21 мар 2022 г. в 13:32
Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated earnings by 10.0%, reporting an EPS loss of 9 cents versus an estimate of a.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
Zacks Investment Research
14 янв 2022 г. в 07:46
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week
PennyStocks
12 дек 2021 г. в 10:52
5 penny stocks to watch this week The post Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.